Prognostic value of normal stress myocardial perfusion imaging in Japanese population - A study based on the J-ACCESS study

Circulation Journal

Volumn 72, Issue 4, 2008, Pages 611-617

  Matsuo, Shinro ^a   Nakajima, Kenichi ^a   Horie, Minora ^b   Nakae, Ichiro ^b   Nishimura, Tsunehiko ^c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Prognosis; Radionuclide imaging; Single photon emission computed tomography (SPECT)

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROGNOSIS; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 43549122061     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.611     Document Type: Article

References (39)

1. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.
2. Berman D, Hachamovitch R, Lewin H, Friedman J, Shaw L, Germano G. Risk stratification in coronary artery disease: Implications for stabilization and prevention. Am J Cardiol 1997; 79: 10-16.
3. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study. J Am Coll Cardiol 1993; 22: 1455-1464.
4. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
5. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
6. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
7. Groutars RG, Verzijlbergen JF, Muller AJ, Ascoop CA, Tiel-van Buul MM, Zwinderman AH, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000; 7: 333-341.
8. Galassi AR, Azzarelli S, Tomaselli A, Giosofatto R, Ragusa A, Musumeci S, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001; 88: 101-106.
9. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM. A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337.
10. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Ethnicity and long-term outcome after an acute coronary event: Multicenter Myocardial Ischemia Research Group. Am Heart J 1999; 138: 500-506.
11. NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70: 1249-1255.
12. Tanihata S, Nishigaki K, Kawasaki M, Takemura G, Minatoguchi S, Fujiwara H. Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1. Circ J 2006; 70: 365-369.
13. Shaw LJ, Hachamovitch R, Heller GV, Marwick TH, Travin MI, Iskandrian AE, et al. Noninvasive strategies for the estimation of cardiac risk: An obseivational assessment of outcome in stable chest pain patients. Am J Cardiol 2000; 86: 1-7.
14. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999; 23: 2140-2145.
15. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998; 32: 57-62.
16. 99mTc-tetrofosmin. Eur J Nucl Med 2002; 29: 46-52.
17. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
18. Hendel RC. Diagnostic and prognostic applications for vasodilator stress myocardial perfusion imaging and the importance of radiopharmaceutical selection. J Nucl Cardiol 2001; 8: 523-527.
19. 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2005; 46: 2003-2008.
20. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T. Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design. Ann Nucl Med 2006; 20: 195-202.
21. 99mTc-tetrofosmin: A multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging 2006; 33: 127-133.
22. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: A study based on the J-ACCESS database. Eur J Nucl Med Mol Imaging 2007; 34: 1088-1096.
23. Matsuo S, Matsumoto T, Nakae I, Koh T, Masuda D, Takada M, et al. Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease. Ann Nucl Med 2004; 18: 617-622.
24. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Film SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999; 33: 2092-2197.
25. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-1824.
26. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995; 26: 1202-1208.
27. Shaw LJ, Miller DD, Romeis JC, Gillespie K, Younis LT, Chaitman BR. Prognostic value of noninvasive risk stratification and coronary revascularization in nonelderly and elderly patients referred for evaluation of clinically suspected coronary artery disease. J Am Geriatr Soc 1996; 44: 1190-1197.
28. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of pre-catheterization ischemia: Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 1999; 33: 661-669.
29. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe: The EMPIRE study. Eur Heart J 1999; 20: 157-166.
30. Shaw LJ, Miller DD, Berman DS, Hachamovitch R. Clinical and economic outcomes assessment in nuclear cardiology. Q J Nucl Med 2000; 44: 138-152.
31. Matsuo S, Nakae I, Matsumoto T, Horie M. Impact of endothelial dysfunction on left ventricular remodeling after successful primary coronary angioplasty for acute myocardial infarction: Analysis by quantitative ECG-gated SPECT. Ann Nucl Med 2006; 20: 57-62.
32. Matsuo S, Nakamura Y, Tsutamoto T, Kinoshita M. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. J Nucl Cardiol 2002; 9: 407-412.
33. Tamaki N. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 2005; 69(Suppl IV): 1125-1202.
34. Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M. A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol 2007; 14: 215-220.
35. Hilton TC, Shaw LJ, Chaitman BR, Stocke KS, Goodgold HM, Miller DD. Prognostic significance of exercise thallium-201 testing in patients aged greater than or equal to 70 years with known or suspected coronary artery disease. Am J Cardiol 1992; 69: 45-50.
36. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-1042.
37. Bateman TM. Clinical relevance of a normal myocardial perfusion scintigraphic study: American Society of Nuclear Cardiology. J Nucl Cardiol 1997; 4: 172-173.
38. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004; 27: 1954-1961.
39. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M. Evaluation of cardiac sympathetic innervations with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 1996; 37: 712-717.